Get started
RocketTickers

Taysha Gene Therapies Reports Positive Clinical Efficacy and Saf

Long
Taysha Gene Therapies, Inc. (NASDAQ:TSHA)  
RocketTickers  
NASDAQ:TSHA   Taysha Gene Therapies, Inc.
Beyond Technical Analysis
2
8
beyondta
TSHA: Taysha Gene Therapies, Inc.
2022-01-31 07:00:00
Taysha Gene Therapies Reports Positive Clinical Efficacy and Safety Data for High Dose Cohort and Long-term Durability Data for TSHA-120 in Giant Axonal Neuropathy
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.